BioSpace News Archive

Pharm Country

GNC Holdings, Inc. Reports Second Quarter 2018 Results

Same store sales decreased 0.4%; excluding impact of loyalty points redeemed, same store sales increased 1.3%

July 26, 2018
·
45 min read
Business

The Medicines Company to Announce Second-Quarter 2018 Financial Results on August 1

The Medicines Company will host a conference call and audio webcast on Wednesday, August 1, 2018, at 8:30 a.m. EDT

July 26, 2018
·
1 min read
Business

Acceleron to Webcast Second Quarter 2018 Operating and Financial Results on August 2, 2018

Acceleron Pharma Inc. announced it will host a webcast and conference call on Thursday, August 2, 2018 at 5:00 p.m. EDT

July 26, 2018
·
1 min read
FDA

LifeSignals Announces FDA Clearance of Health Care Vital Sign Wireless Monitoring Patch and ECG Application

FDA Approval Paves Way for Next Generation of Remote Patient Diagnostics

July 26, 2018
·
3 min read
Biotech Bay

Leading Companies Make Switch to Veeva OpenData to Deliver Accurate Data Faster to Field Teams

Organizations from emerging biopharma to the largest pharmaceutical companies are improving field productivity and driving better customer engagement

July 26, 2018
·
4 min read
Business

Bristol-Myers Squibb Reports Second Quarter 2018 Financial Results

Increases Second Quarter Revenues 11% to $5.7 Billion

July 26, 2018
·
18 min read
Business

Vodori Announces Election of New Board of Directors

The seven board members come from a variety of public and private sector backgrounds.

July 26, 2018
·
5 min read
Business

McKesson Reports Fiscal 2019 First-Quarter Results

Revenues of $52.6 billion for the first quarter, up 3% year over year.

July 26, 2018
·
28 min read
Business

Diagnostics Product and Service Provider MedTest Dx Unveils New Corporate Name Reinforcing Its Integrated Model that Better Serves Customers

Company Growth Reflects Its Seamless Integration of Multiple Established Diagnostics Brands Known for Quality, Customer Service and Innovation

July 26, 2018
·
4 min read
Policy

Sandoz Amends ANDA to Not Seek Approval for Generic Version of OMIDRIA Until Patents for Omeros’ Drug Expire

With Voluntary Dismissal of Infringement Suit Against Sandoz, Omeros Wraps Up All Pending ANDA Litigation

July 26, 2018
·
5 min read